Fecal microbiota transplant protocol for clostridium difficile infection.
William M Tauxe, Tanvi Dhere, Angela Ward, Lori D Racsa, Jay B Varkey, Colleen S Kraft
Author Information
William M Tauxe: Emory University School of Medicine, Atlanta, Georgia.
Tanvi Dhere: Division of Digestive Diseases, Emory University School of Medicine, Atlanta, Georgia.
Angela Ward: Division of Digestive Diseases, Emory University School of Medicine, Atlanta, Georgia.
Lori D Racsa: Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.
Jay B Varkey: Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia.
Colleen S Kraft: Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia colleen.kraft@emory.edu.
Fecal microbiota transplant has become more acceptable as a therapeutic for recurrent Clostridium difficile infection. The FDA has an enforcement discretion policy for practitioner's performing this therapy, which includes informed consent for this experimental treatment. This manuscript describes a typical procedure that can be followed that includes the important aspects of this preparation and treatment.
